Ticker: PYXS

Company Overview Pyxis Oncology, Inc. (NASDAQ: PYXS) is a Delaware-based clinical stage oncology company focused on developing novel therapeutics for treating solid tumors, particularly head and neck squamous cell carcinoma (HNSCC). Recent Financial Performance Net Loss: $21.2 million for Q1 202...